Cover Image

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma

Abstract SMAD4, a tumor suppressor gene, is lost in up to 60%-90% of pancreatic adenocarcinomas (PDAs). Loss of SMAD4 allows tumor progression by upregulating autophagy, a cell survival mechanism that counteracts apoptosis and allows intracellular recycling of macromolecules. Hydroxychloroquine (HCQ...

Full description

Saved in:
Bibliographic Details
Main Authors: Naomi Fei (Author), Sijin Wen (Author), Rajesh Ramanathan (Author), Melissa E. Hogg (Author), Amer H. Zureikat (Author), Michael T. Lotze (Author), Nathan Bahary (Author), Aatur D. Singhi (Author), Herbert J. Zeh (Author), Brian A. Boone (Author)
Format: Book
Published: Wiley, 2021-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items